We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Forma Therapeutics Holdings Inc | NASDAQ:FMTX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 20.01 | 19.98 | 19.40 | 0 | 01:00:00 |
From Aug 2022 to Aug 2024
By Colin Kellaher
Shares of Forma Therapeutics Holdings Inc. took flight Thursday after the clinical-stage biopharmaceutical company agreed to be acquired by Denmark's Novo Nordisk AS for about $1.1 billion.
Novo said it would pay $20 a share in cash for Forma, about 49% above Wednesday's closing price of $13.40 for the Watertown, Mass., company and a more than 90% premium to Forma's 30-day volume-weighted average share price.
The deal is slated to close by the end of the year.
Forma shares were recently changing hands at $19.79, up nearly 48%.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
September 01, 2022 10:04 ET (14:04 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Forma Therapeutics Chart |
1 Month Forma Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
